Carl Zeiss Meditec AG
XETRA:AFX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
54.65
121.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG
Other Liabilities
Carl Zeiss Meditec AG
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
Other Liabilities
€51.9m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
0%
|
|
|
Stratec SE
XETRA:SBS
|
Other Liabilities
€24.4m
|
CAGR 3-Years
9%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Other Liabilities
€86.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Siemens Healthineers AG
XETRA:SHL
|
Other Liabilities
€1.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
Other Liabilities
€366.3m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
0%
|
|
|
Sartorius AG
XETRA:SRT
|
Other Liabilities
€186.8m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
Carl Zeiss Meditec AG
Glance View
Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 3,531 full-time employees. The company went IPO on 2000-03-20. The company offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The firm has various production sites in Europe, the United States and Asia.
See Also
What is Carl Zeiss Meditec AG's Other Liabilities?
Other Liabilities
51.9m
EUR
Based on the financial report for Jun 30, 2024, Carl Zeiss Meditec AG's Other Liabilities amounts to 51.9m EUR.
What is Carl Zeiss Meditec AG's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
0%
Over the last year, the Other Liabilities growth was 31%. The average annual Other Liabilities growth rates for Carl Zeiss Meditec AG have been -19% over the past three years , -6% over the past five years .
You don't have any saved screeners yet
